Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MIKHAIL I SHTIVELBAND

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1740254473
CMS profile
169412
Location
CHANDLER, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$1,960.79

101 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,823.61 98
Education $137.18 3

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 101 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MIKHAIL I SHTIVELBAND

NPI 1740254473 · CMS profile ID 169412

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

CHANDLER, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 101 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1740254473?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MIKHAIL I SHTIVELBAND, NPI 1740254473, CMS profile ID 169412. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 101 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1740254473?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). MIKHAIL I SHTIVELBAND, NPI 1740254473, CMS profile ID 169412. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 101 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1740254473?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
MIKHAIL I SHTIVELBAND, NPI 1740254473, CMS profile ID 169412, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 101 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1740254473?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

101 matching records · $1,960.79 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 101 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 101.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Celgene Corporation $7.0905/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014648971 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.7505/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000513565 CMS
Merck Sharp & Dohme LLC $17.2005/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048288435 CMS
Regeneron Healthcare Solutions, Inc. $24.2105/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999441067 CMS
Celgene Corporation $6.0605/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014648023 CMS
Novartis Pharmaceuticals Corporation $21.9605/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993257421 CMS
CTI BioPharma Corp. $20.3305/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1039693949 CMS
EMD Serono, Inc. $20.5505/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032334431 CMS
AbbVie Inc. $19.5604/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998990683 CMS
Mirati Therapeutics, Inc. $31.6404/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058003525 CMS
AstraZeneca Pharmaceuticals LP $19.8604/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014667925 CMS
Celgene Corporation $5.7804/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014648011 CMS
Kyowa Kirin, Inc. $17.8804/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1027012383 CMS
Amgen Inc. $12.8804/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020032109 CMS
Janssen Biotech, Inc. $3.1504/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988657407 CMS
PFIZER INC. $23.1304/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050569153 CMS
Puma Biotechnology, Inc. $22.5204/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059046099 CMS
Blueprint Medicines Corporation $17.1004/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051259329 CMS
Amgen Inc. $15.5804/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020032111 CMS
Merck Sharp & Dohme LLC $29.3304/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048288459 CMS
Daiichi Sankyo Inc. $19.5304/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006345229 CMS
Novartis Pharmaceuticals Corporation $25.5104/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993257411 CMS
E.R. Squibb & Sons, L.L.C. $15.9903/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014647987 CMS
AbbVie Inc. $21.1803/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998990679 CMS
Novartis Pharmaceuticals Corporation $22.4803/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993257413 CMS
Mirati Therapeutics, Inc. $21.0003/16/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058003523 CMS
E.R. Squibb & Sons, L.L.C. $17.9703/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014647893 CMS
Merck Sharp & Dohme LLC $18.9503/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048727783 CMS
Celgene Corporation $20.0703/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014647999 CMS
Janssen Biotech, Inc. $10.7003/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988657411 CMS
Janssen Biotech, Inc. $1.7703/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988657413 CMS
PFIZER INC. $17.0103/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050403677 CMS
Jazz Pharmaceuticals Inc. $21.2203/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059082467 CMS
AstraZeneca Pharmaceuticals LP $17.9002/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011974207 CMS
Merck Sharp & Dohme LLC $16.0002/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048288439 CMS
Pharmacyclics LLC, An AbbVie Company $22.2002/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998295611 CMS
G1 Therapeutics, Inc. $13.5202/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059916853 CMS
Aadi Bioscience, Inc. $16.4002/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026485775 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.4402/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000512797 CMS
Genentech USA, Inc. $32.9302/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040473479 CMS
EMD Serono, Inc. $19.5702/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032327265 CMS
Novartis Pharmaceuticals Corporation $18.0202/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993257407 CMS
AstraZeneca Pharmaceuticals LP $22.2702/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014724377 CMS
Novartis Pharmaceuticals Corporation $14.6301/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993257405 CMS
PFIZER INC. $14.7401/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049515949 CMS
Janssen Biotech, Inc. $8.4601/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988657415 CMS
Janssen Biotech, Inc. $22.3101/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988657409 CMS
Daiichi Sankyo Inc. $17.9901/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006363925 CMS
Takeda Pharmaceuticals U.S.A., Inc. $33.2101/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055604159 CMS
Celgene Corporation $18.3201/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014647773 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $26,137.87 162
PY2020 $5,395.00 98
PY2021 $2,612.82 171
PY2022 $3,444.92 192
PY2023 $1,960.79 101
PY2024 $1,064.56 57
PY2025 $922.34 39

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $906,720.78 6
PY2024 Principal investigator $693,194.87 10
PY2023 Recipient $1,237.95 1
PY2023 Principal investigator $1,089,983.71 35
PY2022 Recipient $1,146.00 1
PY2022 Principal investigator $1,254,442.06 43
PY2021 Recipient $949.05 1
PY2021 Principal investigator $1,873,783.44 55
PY2020 Recipient $2,884.09 1
PY2020 Principal investigator $1,486,812.85 103
PY2019 Principal investigator $1,797,311.17 110

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

6 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca UK Limited $3,588.01 04/24/2025 Non-covered Recipient Entity
IRONWOOD CANCER AND RESEARCH CENTER CHANDLER I
A Phase 3b, Multicenter, Open-Label, Single-Arm Study of Acalabrutinib (ACP-196) in Subjects with Chronic Lymphocytic Leukemia No dispute reported 06/30/2026 1185541724
Principal investigator 1 Novartis Pharmaceuticals Corporation $22.96 03/26/2025 Non-covered Recipient Entity
IRONWOOD CANCER AND RESEARCH CENTER CHANDLER I
Single-arm, open label, phase II study of MBG453 (sabatolimab) added to FDA approved Hypomethylating agents of investigator's choice (IV/SC/Oral) for patients with intermediate, high or very high risk myelodysplastic syndrome (MDS) as per IPSS-R criteria No dispute reported 06/30/2026 1190308578
Principal investigator 1 Eli Lilly and Company $22,042.00 02/10/2025 Non-covered Recipient Entity
IRONWOOD CANCER AND RESEARCH CENTERS
EMBER-3: A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF LY3484356 VS INVESTIGATOR'S CHOICE OF ENDOCRINE THERAPY, IN PATIENTS WITH ESTROGEN RECEPTOR POSITIVE, HER2 NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH ENDOCRINE THERAPY No dispute reported 06/30/2026 1187885190
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $2,350.00 02/04/2025 Non-covered Recipient Entity
Ironwood Cancer & Researc
A Phase III, Open-Label, Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) versus Rituximab Plus Chemotherapy followed by Rituximab in Subjects with Previously Untreated Follicular Lymphoma No dispute reported 06/30/2026 1235996527
Principal investigator 1 AstraZeneca Pharmaceuticals LP $294,777.11 01/15/2025 Non-covered Recipient Entity
IRONWOOD CANCER AND RESEARCH CENTER CHANDLER I
A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with unresected Stage I/II, lymph-node negative Non-small Cell Lung Cancer (PACIFIC-4/RTOG-3515) No dispute reported 06/30/2026 1185541722
Principal investigator 1 Novartis Pharmaceuticals Corporation $583,940.70 01/02/2025 Non-covered Recipient Entity
IRONWOOD CANCER AND RESEARCH CENTER CHANDLER I
A Post-trial Access Roll-over Study to Allow Access to Ribociclib (LEE011) for Patients Who Are on Ribociclib Treatment in Novartis-sponsored Study No dispute reported 06/30/2026 1190308576